Ionization states of the catalytic residues in hiv-1 protease


Play all audios:

Loading...

ABSTRACT Chemical synthesis was used to prepare the HIV-1 protease specifically 13C-labelled in the catalytically essential Asp 25 in each monomer. The NMR chemical shift of the 13C-enriched


homodimeric enzyme was measured in the presence of the inhibitor pepstatin, a mimic of the tetrahedral intermediate formed in enzyme catalysis. In this complex, the catalytic carboxyls do


not titrate in the pH range where the enzyme is active; throughout the range pH 2.5–6.5, one Asp 25 side chain is protonated and the other deprotonated. By contrast, in the absence of


inhibitor the two Asp side chains are chemically equivalent and both deprotonated at pH 6, the optimum for enzymatic activity. These direct observations of the chemical properties of the


catalytic apparatus of the enzyme provide concrete information on which to base the design of improved HIV-1 protease inhibitors. Access through your institution Buy or subscribe This is a


preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per


year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated


during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS AUTOPROCESSING


AND OXYANION LOOP REORGANIZATION UPON GC373 AND NIRMATRELVIR BINDING OF MONOMERIC SARS-COV-2 MAIN PROTEASE CATALYTIC DOMAIN Article Open access 16 September 2022 CRYO-EM STRUCTURES OF HUMAN


A2ML1 ELUCIDATE THE PROTEASE-INHIBITORY MECHANISM OF THE A2M FAMILY Article Open access 31 May 2022 ALLOSTERY IN HOMODIMERIC SARS-COV-2 MAIN PROTEASE Article Open access 04 November 2024


REFERENCES * Ratner, L. _et al_. Complete nucleotide sequence of the AIDS virus, HTLV-III. _Nature_ 313, 277–284 (1985). CAS  Google Scholar  * Oroszlan, S. in _Viral Proteinases as Targets


For Chemotherapy_ (Eds H. Kräusslich, S. Oroszlan, E. Wimmer) 87–100 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989). Google Scholar  * McQuade, T.J. _et al_. A synthetic


HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. _Science_ 247, 454–456 (1990). Article  CAS  Google Scholar  * Huff, J.R. HIV protease: a novel


chemotherapeutic target for AIDS. _J. Med. Chem._ 34, 2305–2314 (1991). Article  CAS  Google Scholar  * Cohen, J. Results on new AIDS drugs bring cautious optimism. _Science._ 271, 755–756


(1996). Article  CAS  Google Scholar  * FDA Press Release (♯95–10), 7 December (1995); and, (♯96–4), 1 March (1996). * Rose, R.E. _et al_. Human immunodeficiency virus type 1 viral


background plays a major role in development of resistance to proteinase inhibitors. _Proc. Natl. Acad. Sci. USA_ 93, 1648–1653 (1996). Article  CAS  Google Scholar  * Condra, J.H. _et al_.


_In vivo_ emergence of HIV-1 variants resistant to multiple protease inhibitors. _Nature_ 374, 569–571 (1995). Article  CAS  Google Scholar  * Hartsuck, J.A. & Tang, J. The carboxylate


ion in the active center of pepsin. _J. Biol. Chem._ 247, 2575–2580 (1972). CAS  PubMed  Google Scholar  * Pearl, L.H. & Taylor, W.R. A structural model for the retroviral proteases.


_Nature_ 329, 351–354 (1987). Article  CAS  Google Scholar  * Pretsch, E., Clerc, T., Seibl, J. & Simon, W. _Spectral Data for Structure Determination of Organic Compounds_


(Springer-Verlag, Berlin, 1989). Book  Google Scholar  * Holladay, M.W., Salituro, F.G. & Rich, D.H. Synthetic and enzyme inhibition studies of pepstatin analogues containing


hydroxyethylene and ketomethylene dipeptide isosteres. _J. Med. Chem._ 30, 374–383 (1987). Article  CAS  Google Scholar  * Toth, M.V. & Marshall, G.R. A simple, continuous fluorometric


assay for HIV protease. _Int. J. Pept. Protein. Res._ 36, 544–550 (1990). Article  CAS  Google Scholar  * Hyland, L.J., Tomaszek, T.A. & Meek, T.D. Human immunodeficiency virus-1


protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. _Biochemistry_ 30, 8454–8463 (1991). Article  CAS  Google Scholar  *


Furfine, E.S. _et al_. Two-step binding mechanism for HIV protease inhibitors. _Biochemistry_ 31, 7886–7891 (1992). Article  CAS  Google Scholar  * Yamazaki, T. _et al_. NMR and X-ray


evidence that the HIV protease catalytic aspartyl groups are protonated in the complex formed by the protease and a non-peptide cyclic urea-based inhibitor. _J. Amer. Chem. Soc._ 116,


10791–10792 (1994). Article  CAS  Google Scholar  * Fitzgerald, P.M.D. _et al_. Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and


acetyl-pepstatin at 2.0-Å resolution. _J. Biol. Chem._ 265, 14209–14219 (1990). CAS  PubMed  Google Scholar  * McDaniel, D.H. & Brown, H.C. Hydrogen bonding as a factor in the ionization


of dicarboxylic acids. _Science_ 118, 370–374 (1953). Article  CAS  Google Scholar  * Frey, P.A., Whitt, S.A. & Tobin, J.B. A low-barrier hydrogen bond in the catalytic triad of serine


proteinases. _Science_ 264, 1927–1930 (1994). Article  CAS  Google Scholar  * Marciniszyn, J.A., Hartsuck, J.A. & Tang, J.J. Mode of inhibition of acid proteases by pepstatin. _J. Biol.


Chem._ 251, 7088–7094 (1976). CAS  PubMed  Google Scholar  * Marshall, G.R. Structure-activity relations of antagonists of the reninangiotensin system. _Fed. Proc._ 35, 2494–2501 (1976). CAS


  PubMed  Google Scholar  * Suguna, K., Padlan, E.A., Smith, C.W., Carlson, W.D. & Davies, D.R. Binding of a reduced bond peptide inhibitor to the aspartic proteinase from _rhizopus


chinesis_: implications for a mechanism of action. _Proc. Natl. Acad. Sci. USA_ 84, 7009–7013 (1987). Article  CAS  Google Scholar  * Schnölzer, M. & Kent, S.B.H. Constructing proteins


by dovetailing unprotected synthetic peptides: backbone-engineered HIV protease. _Science_ 256, 221–225 (1992). Article  Google Scholar  * Tóth, G. & Penke, B. An improved method for the


preparation of omega-cyclohexyl esters of aspartic and glutamic acid. _Synthesis_ 361–362 (1992). Article  Google Scholar  * Schnölzer, M., Alewood, P., Jones, A., Alewood, D. & Kent,


S.B.H. _In situ_ neutralization in Boc-chemistry sol id phase peptide synthesis: rapid, high yield assembly of difficult sequences. _Int. J. Pept. Protein Res._ 40, 180–193 (1992). Article 


Google Scholar  * Grant, S.K. _et al_. Use of protein folding studies to determine the conformational and dimer stabilities of HIV-1 and SIV proteases. _Biochemistry_ 31, 9491–9501 (1992).


Article  CAS  Google Scholar  * Wlodawer, A. _et al_. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. _Science_ 245, 616–621 (1989). Article  CAS


  Google Scholar  * Mildner, A.M. _et al_. The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.


_Biochemistry_ 33, 9405–9413 (1994). Article  CAS  Google Scholar  * Bergman, D.A. _et al_. Kinetic properties of HIV-1 protease produced by total chemical synthesis with cysteine residues


replaced by isosteric L-α-_n_-butyric acid. _Lett. Pept. Sci._ 2, 99–107 (1995). Article  CAS  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of


Biochemistry, University of Queensland, Qld, 4072, Australia Ross Smith * Center for Magnetic Resonance, University of Queensland, Qld, 4072, Australia Ian M. Brereton * The Scripps


Research Institute, La Jolla, California, 92037, USA Richard Y. Chai & Stephen B.H. Kent Authors * Ross Smith View author publications You can also search for this author inPubMed Google


Scholar * Ian M. Brereton View author publications You can also search for this author inPubMed Google Scholar * Richard Y. Chai View author publications You can also search for this author


inPubMed Google Scholar * Stephen B.H. Kent View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS


ARTICLE CITE THIS ARTICLE Smith, R., Brereton, I., Chai, R. _et al._ Ionization states of the catalytic residues in HIV-1 protease. _Nat Struct Mol Biol_ 3, 946–950 (1996).


https://doi.org/10.1038/nsb1196-946 Download citation * Received: 20 May 1996 * Accepted: 20 September 1996 * Issue Date: 01 November 1996 * DOI: https://doi.org/10.1038/nsb1196-946 SHARE


THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to


clipboard Provided by the Springer Nature SharedIt content-sharing initiative